Xspray Pharma

Image of a neon sign with the word no lit up next to an unlit yes
Pharma

Xspray hits FDA wall with new manufacturing-related rejection

It's the third FDA complete response letter for Xspray during its repeated attempts to launch Dasynoc, a leukemia med based on a BMS' blockbuster.
Zoey Becker Oct 9, 2025 9:23am
FDA

After rejection, FDA accepts Xspray's leukemia med resubmission

Feb 12, 2024 10:33am
Gavel with scales of justice in background

BMS settles with Xspray, clearing way for 2024 Dasynoc launch

Sep 12, 2023 10:16am
Stop sign

FDA rejects Xspray's would-be rival to BMS leukemia med Sprycel

Jul 11, 2023 9:55am